CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

Changchun High-Tech Industry (Group) Co., Ltd.

000661

CNE0000007J8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
110.9 ^CNY	+0.45%		-8.26%	-23.94%

Apr. 19	Changchun High-Tech Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 12	Changchun High-Tech Industries Inc. Implements Final Dividend on A Shares for 2023, Payable on 18 April 2024	CI

Qiao Lin acquired 0.003% in Changchun High & New Technology Industries Inc..

August 24, 2015 at 12:00 am EDT

Qiao Lin acquired 0.003% in Changchun High & New Technology Industries (Group) Inc. (SZSE:000661) on August 21, 2015. As per the agreement 4000 shares are acquired.

Qiao Lin completed the acquisition of 0.003% in Changchun High & New Technology Industries (Group) Inc. (SZSE:000661) on August 21, 2015.

Latest news about Changchun High-Tech Industry (Group) Co., Ltd.

Changchun High-Tech Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Changchun High-Tech Industries Inc. Implements Final Dividend on A Shares for 2023, Payable on 18 April 2024	Apr. 12	CI
Changchun High-Tech Industries Inc. has Changed its Name to Changchun High-Tech Industry Co., Ltd	Apr. 10	CI
Changchun High & New Technology's 2023 Profit Rises 9.5% on Higher Revenue	Mar. 20	MT
Changchun High-Tech Industries Inc. Proposes Final Dividend for 2023	Mar. 19	CI
Changchun High-Tech Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Changchun High-Tech Industries Inc. announces an Equity Buyback for CNY 120 million worth of its shares.	Jan. 19	CI
Changchun High-Tech Industries Inc. authorizes a Buyback Plan	Jan. 18	CI
Changchun High & New Technology Founder Transfers Stake to Ex-Wife in Divorce Settlement	Jan. 14	MT
Changchun High-Tech Industry's Unit Gets Nod for Registration of Follicle-Stimulating Hormone Injection	Jan. 10	MT
Changchun High-Tech Industry Gets Green Light to Trial EG017 Ointment	Jan. 09	MT
Changchun High-Tech Industry's Unit to Trial GenSci125 for Injection	Dec. 15	MT
Changchun High-Tech Industry's Unit Gets Nod to Trial Rabies Vaccine	Dec. 07	MT
Changchun Hi-tech Investment Co., Ltd. cancelled the acquisition of Changchun High-tech Real Estate Development Co., Ltd. from Changchun High-Tech Industries Inc..	Nov. 22	CI
Changchun High-Tech Industry Unit Gets Nod to Test Tetanus Vaccine	Nov. 01	MT
Changchun High-Tech Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Tranche Update on Changchun High-Tech Industries Inc.'s Equity Buyback Plan announced on September 2, 2023.	23-10-09	CI
Changchun High & New Technology Industries' Subsidiary Buys Land for 162 Million Yuan	23-09-27	MT
Changchun High-Tech Industries Inc. announces an Equity Buyback for CNY 200 million worth of its shares.	23-09-01	CI
Changchun High-Tech Industries Inc. authorizes a Buyback Plan.	23-08-31	CI
Changchun High-Tech Industries Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Changchun High-Tech Industries Inc.'s Board intends to launch an Equity Buyback.	23-08-23	CI
Changchun High & New Technology Says Speculations Over Zhejiang Procurement Policy Drive Stock Fluctuation	23-06-12	MT
Changchun High Unit Gets Nod to Trial Acinarizumab for Injection	23-05-26	MT
Changchun High-Tech Industries Inc. Approves Final Cash Dividend for the Year of 2022, Payable on 28 April 2023	23-04-20	CI

Chart Changchun High-Tech Industry (Group) Co., Ltd.

Duration

Period

Chart Changchun High-Tech Industry (Group) Co., Ltd.

More charts

Company Profile

Changchun High-Tech Industry (Group) Inc. specializes in the manufacturing and marketing of biopharmaceutical products. Products include polyethylene glycol-based recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, lyophilized live varicella vaccines and rabies vaccines for human use.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Changchun High-Tech Industry (Group) Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

110.9 CNY

Average target price

195.3 CNY

Spread / Average Target

+76.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.	-23.94%	6.13B
ELI LILLY AND COMPANY	+27.92%	659B
NOVO NORDISK A/S	+27.68%	557B
JOHNSON & JOHNSON	-4.59%	359B
MERCK & CO., INC.	+16.38%	322B
ABBVIE INC.	+9.39%	297B
ASTRAZENECA PLC	+6.30%	215B
NOVARTIS AG	+4.80%	210B
ROCHE HOLDING AG	-6.05%	200B
PFIZER, INC.	-8.58%	149B

Other Pharmaceuticals

Changchun High-Tech Industry (Group) Co., Ltd.

Equities

000661

CNE0000007J8

Pharmaceuticals

Qiao Lin acquired 0.003% in Changchun High & New Technology Industries Inc..

Latest news about Changchun High-Tech Industry (Group) Co., Ltd.

Chart Changchun High-Tech Industry (Group) Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Changchun High-Tech Industry (Group) Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals